Case control study of hormone replacement therapy (HRT) and breast cancer in Japanese women.

被引：0
|
作者：
Takeuchi, M.
Saeki, T.
Sano, M.
Sonoo, H.
Honjo, H.
Ochiai, K.
Sugano, H.
Komiike, Y.
机构：
[1] Kitasato Univ, Tokyo 108, Japan
[2] Saitama Med Sch, Iruma, Japan
[3] Niigata Canc Ctr, Niigata, Japan
[4] Kawasaki Med Sch, Kurashiki, Okayama, Japan
[5] Kyoto Prefectural Univ Med, Kyoto 602, Japan
[6] Jikei Univ, Sch Med, Tokyo 105, Japan
[7] Osaka Med Ctr Canc, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10012
引用
收藏
页码：544S / 544S
页数：1
相关论文
共 50 条
  • [21] Hormone replacement therapy and the development of knee osteoarthritis in elderly white women. A case-control study.
    Brantus, J
    Reading, L
    Cooper, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S282 - S282
  • [22] Use of hormone replacement therapy (HRT) and survival following breast cancer diagnosis
    Fletcher, AS
    Erbas, B
    Kavanagh, AM
    Hart, S
    Rodger, A
    Gertig, DM
    BREAST, 2005, 14 (03): : 192 - 200
  • [23] Current HRT (hormone replacement therapy) use at diagnosis of breast cancer does not adversely affect survival from symptomatic or screen detected breast cancers in postmenopausal women.
    Prasad, R
    Wilson, M
    Morris, J
    Byrne, G
    Bundred, NJ
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S131 - S132
  • [24] Breast cancer and hormone-replacement therapy in the Million Women Study
    Crosignani, PG
    MATURITAS, 2003, 46 (02) : 91 - 92
  • [25] Breast cancer and hormone-replacement therapy: the Million Women Study
    Gray, S
    LANCET, 2003, 362 (9392): : 1332 - 1332
  • [26] Breast cancer and hormone-replacement therapy in the Million Women Study
    Banks, E
    Beral, V
    Bull, D
    Reeves, G
    Austoker, J
    English, R
    Patnick, J
    Peto, R
    Vessey, M
    Wallis, M
    Abbott, S
    Bailey, E
    Baker, K
    Balkwill, A
    Barnes, I
    Black, J
    Brown, A
    Cameron, B
    Canfell, K
    Cliff, A
    Crossley, B
    Couto, E
    Davies, S
    Ewart, D
    Ewart, S
    Ford, D
    Gerrard, L
    Goodill, A
    Green, J
    Gray, W
    Hilton, E
    Hogg, A
    Hooley, J
    Hurst, A
    Kan, SW
    Keene, C
    Langston, N
    Roddam, A
    Saunders, P
    Sherman, E
    Simmonds, M
    Spencer, E
    Strange, H
    Timadjer, A
    LANCET, 2003, 362 (9382): : 419 - 427
  • [27] Effects of raloxifene (RLX), hormone replacement therapy (HRT) and placebo (PL) on bone turnover in postmenopausal women.
    Weinstein, RS
    Parfitt, AM
    Marcus, R
    Bekele, B
    Wong, M
    Muchmore, DB
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S279 - S279
  • [28] Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT
    Ken-ichirou Morishige
    Toshiya Yamamoto
    Kenjiro Sawada
    Masahide Ohmichi
    Keiichi Tasaka
    Yuji Murata
    Archives of Gynecology and Obstetrics, 2003, 268 (2) : 105 - 106
  • [29] Discussing breast cancer and hormone replacement therapy with women
    Batur, P
    Thacker, HL
    Moore, HCF
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2002, 69 (11) : 838 - +
  • [30] Hormone replacement therapy in women with a history of breast cancer
    Ylikorkala, O
    Metsä-Heikkilä, M
    GYNECOLOGICAL ENDOCRINOLOGY, 2002, 16 (06) : 469 - 478
12345